Loading clinical trials...
Loading clinical trials...
Does the Bioactive Substance in Coffee, Cafestol, Have Preventive Properties on Type-2-diabetes? Acute and Longer-term Metabolic Effects of Cafestol. (Acute Substudy)
Conditions
Interventions
Cafestol 12 mg
Placebo
+1 more
Locations
1
Denmark
Steno Diabetes Center Aarhus
Aarhus, Aarhus N, Denmark
Start Date
May 25, 2021
Primary Completion Date
September 16, 2021
Completion Date
September 16, 2021
Last Updated
February 28, 2022
NCT06287632
NCT07125638
NCT03605121
NCT05529199
NCT05310721
NCT02986659
Lead Sponsor
University of Aarhus
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions